News

All Categories

10 November 2021

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

News

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

Media Release

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

Media Release

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

Media Release

10 September 2021

OneVentures launches new Responsible Investment Policy, putting the company’s money where the future is

Blog Post, Announcement

28 September 2021

LiveTiles has its sights set on growth with $10m loan

News

27 September 2021

LiveTiles secures $10m debt facility to drive strategic growth

News

21 September 2021

Investment Notes: Flippa

Blog Post, Investment Notes

20 September 2021

Selling a company as easy as posting an eBay listing

News, The Australian Financial Review

20 September 2021

Flippa raises $11M to match online asset and business buyers, sellers

News

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

Announcement, Media Release

25 July 2021

Tech sector demands a plan to escape lockdown crisis

News, The Australian Financial Review

25 July 2021

Forget unicorns, OneVentures has a start-up dragon

News, The Australian Financial Review

24 July 2021

Permanent Artificial Hearts Are Closer Than You Think

News

07 July 2021

‘Just like Netflix’: Southern Cross backs AI start-up

News, The Australian Financial Review

04 July 2021

Hivery scores debt from OneVentures in 10th credit deal

News, The Australian Financial Review

08 June 2021

QLD govt commits $20m to vaccine manufacturer

News

02 June 2021

Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine

News, Media Release

02 June 2021

No need for needle as COVID-19 vaccination patch shows promise

News, Sydney Morning Herald

30 March 2021

Lumary secures $17 million for tech designed to help service providers navigate the NDIS

News, Smart Company

29 March 2021

Lumary raises $17m from OneVentures, Salesforce

News, The Australian Financial Review

29 March 2021

Investment Notes: Lumary

Blog Post, Investment Notes

02 March 2021

Australia-based Employment Hero raises $45M AUD for its global expansion

News

02 March 2021

HR tech firm raises $45m amid remote working boom

News, The Australian Financial Review

decor decor decor
decor decor decor decor decor